Trial of Andexanet in Patients Receiving an Oral FXa Inhibitor Who Require Urgent Surgery

Clinical Trial Site, Vienna

Clinical Trial Site, Innsbruck

Clinical Trial Site, Graz

Clinical Trial Site, Klagenfurt

Clinical Trial Site, Staten Island

Clinical Trial Site, Pittsburgh

Clinical Trial Site, Pittsburgh

Clinical Trial Site, Philadelphia

Clinical Trial Site, Washington D.C.

Clinical Trial Site, Dijon

Clinical Trial Site, Durham

Clinical Trial Site, Charlotte

Clinical Trial Site, Tampa

Clinical Trial Site, Sarasota

Clinical Trial Site, Giessen

Clinical Trial Site, Columbus

Clinical Trial Site, Nantes

Clinical Trial Site, Dortmund

Clinical Trial Site, Cologne

Clinical Trial Site, Aachen

Clinical Trial Site, Iowa City

Clinical Trial Site, Bonn

Clinical Trial Site, Mainz

Clinical Trial Site, Lille

Clinical Trial Site, Clermont-Ferrand

Clinical Trial Site, Heidelberg

Clinical Trial Site, Tulsa

Clinical Trial Site, Paris

Clinical Trial Site, Paris

Clinical Trial Site, Konstanz

Clinical Trial Site, Freiburg im Breisgau

Clinical Trial Site, Murnau am Staffelsee

Clinical Trial Site, Phoenix

Clinical Trial Site, Tucson

Clinical Trial Site, Long Beach

Clinical Trial Site, Jerusalem

Clinical Trial Site, Moreno Valley

Clinical Trial Site, Würzburg

Clinical Trial Site, Portland

Clinical Trial Site, Haifa

Clinical Trial Site, Petah Tikva

Clinical Trial Site, Ashkelon

Clinical Trial Site, Jerusalem

Clinical Trial Site, Boston

Clinical Trial Site, Boston

Clinical Trial Site, Camden

Clinical Trial Site, Kamakura

Clinical Trial Site, Kasuga

Clinical Trial Site, Kawasaki

Clinical Trial Site, Kumamoto

Clinical Trial Site, Kumamoto

Clinical Trial Site, Kurume

Clinical Trial Site, Nagoya

Clinical Trial Site, Sakai

Clinical Trial Site, Sendai

Clinical Trial Site, Tokyo